Stéphane Bancel, Moderna CEO (Hollie Adams/Bloomberg via Getty Images)
FDA approves Moderna's RSV vaccine, marking its second commercial product
Moderna on Friday secured a long-awaited but expected approval for its RSV vaccine, giving the biotech its first FDA approval for a non-Covid-19 product and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
